Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 New Yorker files class-action lawsuit against manufacturers of weight loss drug
2 To Your Good Health: The weight loss battle continues
3 Infringement of non-working patents: 'Clearing the way' for interim reliefs?
4 Phenotype-based therapy leads to greater weight loss in obesity
5 Major Breakthrough in Weight Loss With Semaglutide?
6 5 Best Weight Loss Pills and Diet Supplements of 2020
7 A weight management physician discusses 4 popular weight loss drugs
8 A Closer Look at FDA Decision to Pull Lorcaserin
9 Alvogen Korea's Qsymia replaces Saxenda as top obesity treatment
10 Eisai Begins Phase 3 Trial Testing Lorcaserin at Reducing Dravet...
11 Weight-loss drug Belviq recalled
12 Anti-Obesity Prescription Drugs Market Report, History And Forecast 2020-2027, Breakdown Data By Manufacturers, Key Regions, Types And Application
13 Weight loss drug Belviq tied to 'possible increased risk of cancer,' FDA says
14 Health and Weight Management Market 2020 Industry Size, Share, Price, Trend and Forecast to 2025
15 As one drug leaves the weight-loss market, many options remain
16 Lorcaserin (Belviq) Withdrawn From US Market Due to Cancer Risk
17 Weight Loss Drug Belviq Found to Increase Cancer Risk, Pulled from Shelves
18 FDA Warns Consumers to Stop Using Belviq® (Lorcaserin) Weight Loss Drug Due to Increased Cancer Risk • LegalScoops
19 CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA
20 Diet Drug Belviq May Raise Cancer Risk: FDA
21 Anti-Obesity Prescription Market: Global Analysis Of Key Manufacturers, Dynamics & Forecast 2020-2026
22 Hudson Valley woman claims Belviq weight-loss drugmaker knew of cancer risk
23 Diet drug Belviq pulled from shelves for possible link to cancer risk
24 FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk
25 Class-Action Lawsuit Filed Against Makers of Dangerous Weight Loss Drug Belviq
26 FDA requests market withdrawal of weight-loss drug Belviq
27 Eisai Initiates Phase 3 MOMENTUM 1 Clinical Trial (Study 304) of Lorcaserin in Dravet Syndrome
28 Weight Loss Drug Belviq Pulled From Market for Possible Cancer Risk
29 FDA drug recall: Weight loss pill may increase cancer risk
30 Anti-Obesity Medications May Prevent Weight Regain After Bariatric Surgery
31 Eisai may be the biggest loser, but it's not the only loser with Belviq withdrawal
32 Drugs Helped Stop Weight Regain After Gastric Bypass
33 Did Patients Trade Weight Loss Concerns for Cancer Concerns?
34 Weight-loss drug Belviq increases risk of cancer, FDA warns
35 Best Weight Loss Pills in 2020
36 Liraglutide a Viable Add-On for Kids With Obesity
37 Alvogen's obesity drug threatens Novo Nordisk's stronghold in Korea
38 NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions
39 Despite Obesity Epidemic, Doctors Don't Prescribe Obesity Drugs
40 Diabetes medication: List, alternatives, and developments
41 FDA Accepts Eisai's Supplemental New Drug Application (sNDA) to Update the Labeling for Anti-Obesity Agent BELVIQ® (lorcaserin HCl)
42 VVUS: Fourth Quarter and Full Year 2019 Results
43 Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
44 Taiwan pulls weight-loss drug from market over cancer concerns
45 Newly discovered brain response to obesity drug may inform future treatments
46 Bae Suzy Weight Loss Diet
47 New Safer Diet Drugs
48 Experts rated weight-loss drugs and Qsymia came out on top
49 Anti-Obesity Therapeutics Market Research Report, Revenue, Manufactures and Forecast Until 2028
50 More Anti-Obesity Drugs for Teens Coming, Devices Are Next Step
51 Doctors warn against use of weight-loss drug
52 Will Novo’s big thinking in obesity pay off?
53 VVUS: First Quarter 2020 Results
54 The diet pills that may help you lose weight and are backed by scientific research
55 Metformin and weight loss: Does this drug help?
56 Which Weight-Loss Drug Works Best?
57 Low Energy Diets for People with Type 2 Diabetes Mellitus
58 Novo Nordisk's big obesity ambitions take shape with semaglutide win
59 FDA Recalls Weight-Loss Drug Due to Heightened Cancer Risk
60 The battle for weight loss continues
61 Status Report of the US Weight Loss Market in 2020
62 Liraglutide adjuvant therapy found to increase weight loss in obese adolescents
63 Best Weight Loss Pills
64 NICE rejections continue, hitting Novo's Saxenda next
65 Royal Society of Medicine: Respect and Treat Obesity Like Any Other Endocrine Disease
66 Regulator pushed voluntary recall of Belviq without data review
67 To Your Good Health: The battle for weight loss continues
68 Obesity Market Spotlight, 2020: Epidemiology, Marketed & Pipeline Drugs, Revenue Opportunities, Clinical Trial Landscape
69 Weight Loss and Obesity Management Market to Surpass US$ 294.2 Billion, Globally, by 2027 at a CAGR of 7.1%, Says Coherent Market Insights
70 Metformin May Stop Weight Regain After Initial Loss
71 Coadministration of phentermine, lorcaserin increases weight loss, not adverse events in adults with obesity
72 Eisai obesity drug Belviq may have an edge with new heart-safety data—but to what end?
73 Calcium Pyruvate: Benefits, Weight Loss, and Side Effects
74 Lorcaserin Is Safe, 'Moves Needle' for Weight Loss in CAMELLIA
75 Five diet drugs: which ones work?
76 Orlistat-acarbose combination may facilitate weight loss with fewer GI effects vs. orlistat alone
77 Weight Loss Pills and Supplements: Do They Work?
78 Diet Pills: Approved, Yes. Prescribed? Maybe
79 Obesity Drug Belviq Is Heart Safe in Cardiovascular Outcome Study
80 Novo Nordisk taps Noom for digital help with its push into obesity
81 Is Contrave Worth Trying?
82 Why New Diet Drugs, Belviq and Qsymia, Are Just in Time
83 Slippery Slope: Diet Drugs No Help for Heart
84 U.S. weight loss drug lorcaserin 'safe' but only modestly effective
85 Lorcaserin and Phentermine Safe Combo in Weight-Loss Trial
86 The battle to lose weight | Feature
87 Belviq: 5 Things You Need to Know About the New Weight-Loss Pill | TIME.com
88 Drugmaker cancels event for 1000 doctors due to new coronavirus risk
89 FDA Approves Liraglutide (Saxenda) for Weight Loss
90 50 Pounds Lighter, Reporter Still Belviq Fan
91 Eisai and Arena Pharmaceuticals Announce Presentation of BELVIQ® (lorcaserin HCl) Data at 2016 Annual Obesity Week Meeting
92 Can popping a pill ever beat obesity? We ask the experts for the pros and cons
93 Weight-loss pill hailed as 'holy grail' in fight against obesity
94 Eisai takes control of weight loss drug Belviq from Arena
95 Saxenda debuts in US with $1000-a-month price tag
96 Everything you need to know about lorcaserin
97 Contrave, Newest Weight Loss Option: FAQ
98 Weight-loss pill Belviq is NOT Recommend
99 Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management
100 Liraglutide as Saxenda for Obesity